Despite significant spending on healthcare in the US, the industry is slow to adopt AI technology that can cut costs and improve efficiency.
In this CPI TechREG article, “A Tale of Two Stakeholder Groups in Regulating Healthcare AI” CRA’s Yajing Jiang and Ishuwar Seetharam, in collaboration with Berkeley Research Group’s Arpita Patnaik, assess the use of AI applications by healthcare providers (e.g., hospitals and physicians) and health insurers (e.g., private payers), and outline the benefits of AI, areas for antitrust concerns, and ways to mitigate these concerns.
Based on this analysis, the authors stress the importance of employing guardrails to address specific antitrust issues, rather than blanket prohibitions, to retain the benefits of AI’s use in healthcare.
